Liquid Biopsy and Early Cancer Detection Tech
Source:The Hindu ↗
Why It Matters
Advances in cancer diagnostics, specifically concepts like liquid biopsy and exosomes, are highly relevant to the Science & Technology section of the UPSC syllabus. Understanding these cutting-edge medical technologies helps address questions related to applied biotechnology and healthcare innovations.
Summary
An expert from the University of Texas MD Anderson Cancer Center, Dr. Raghu Kalluri, presented a groundbreaking method for early cancer detection using liquid biopsies. The technique relies on 'exosomes'—tiny cell-released vesicles—acting as biomarkers in the bloodstream, enabling the early diagnosis of aggressive cancers like pancreatic cancer. The approach also highlights new treatments targeting the structural environment around tumors, such as fibroblasts and collagen, rather than just the cancer cells themselves, to prevent the disease from spreading.
Key Points
- Scientist Dr. Raghu Kalluri unveiled a novel approach to early cancer detection using 'liquid biopsies' at GITAM Deemed to be University.
- The new diagnostic method utilizes 'exosomes'—microscopic vesicles released by cells—as biomarkers to detect aggressive cancers, including pancreatic cancer, at a very early stage.
- Instead of solely targeting the cancer cells, cutting-edge therapies now aim to attack the structural framework surrounding the tumor, specifically fibroblasts and collagen, to prevent metastasis.
- This breakthrough approach could transform cancer from a fatal illness into a manageable condition.
Important Terms
Liquid Biopsy
A non-invasive diagnostic method that detects cancer by analyzing biological fluids, such as blood, for circulating tumor DNA (ctDNA), cells, or other tumor-derived components.
UPSC context
GS Paper 3 (Science and Tech); relevant for advancements in non-invasive diagnostics and precision oncology.
Exosomes
Small extracellular vesicles released by cells that carry proteins and genetic material; they serve as critical biomarkers for early-stage disease detection and intercellular communication.
UPSC context
GS Paper 3 (Biotechnology); tests knowledge of cellular biology and innovative diagnostic tools in medicine.
Biomarkers
Measurable biological indicators (like DNA, proteins, or metabolites) used to identify normal processes, disease states, or responses to medical treatments.
UPSC context
GS Paper 3 (Science and Tech); essential for topics on medical diagnostics, public health, and personalized medicine.
Tumor Microenvironment (TME)
The complex biological ecosystem surrounding a tumor, including immune cells, blood vessels, and structural components like the extracellular matrix, which influences cancer progression.
UPSC context
GS Paper 3 (Health/Biotechnology); examines factors driving disease resistance and the development of targeted therapies.
Cancer-Associated Fibroblasts (CAFs)
Activated cells within the tumor microenvironment that produce structural proteins like collagen and promote cancer growth, invasion, and therapeutic resistance.
UPSC context
GS Paper 3 (Biotechnology); focuses on specific cellular targets in advanced cancer research and treatment strategies.
MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a globally recognized institution dedicated to cancer patient care, research, education, and groundbreaking clinical trials.
UPSC context
GS Paper 3 (Science and Tech); representative of premier global institutions driving international medical research and innovation.
Prelims Trap
"Exosomes are synthetically engineered nanoparticles introduced into the blood to deliver targeted cancer therapy."
Exosomes are naturally occurring extracellular vesicles released by cells into bodily fluids, not artificially engineered nanoparticles. While they hold potential for drug delivery, they are fundamentally natural biomarkers.
Static Concepts Connected
How does a Liquid Biopsy differ from a Traditional Biopsy?
- Liquid Biopsy: A non-invasive diagnostic test analyzing blood or other bodily fluids to detect circulating tumor DNA, tumor cells, or exosomes.
- Traditional Biopsy: An invasive clinical procedure requiring the physical and surgical extraction of tissue directly from a suspected tumor site for examination.
What is the role of Biomarkers in disease diagnosis?
- Definition: Measurable biological, genetic, or biochemical molecules found in blood, other body fluids, or tissues that indicate a normal or abnormal process.
- Clinical Application: Essential in precision medicine for early disease screening, diagnosing specific cancers, and monitoring patient response to targeted therapeutic drugs.
Cross-Topic Patterns
NCD burden and National Health Mission
Innovations in early cancer detection directly support the National Programme for Prevention and Control of NCDs (NP-NCD), addressing India's epidemiological shift towards lifestyle diseases.
Evolution of Cancer Therapeutics
Connects with UPSC's focus on targeted biotechnology applications (like CAR-T cell therapy), shifting from broad systemic chemotherapy to precision medicine targeting specific tumor microenvironments.
Expect a multi-statement Prelims question comparing 'liquid biopsies' with traditional biopsies, or querying the natural origin of 'exosomes'.
Linked PYQs · 3
Linked PYQs · 3
- 2021MainsGS3
What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of the society?
- 2020MainsGS3
What do you understand by nanotechnology and how is it helping in health sector?
- 2020PrelimsGS1
With reference to carbon nanotubes, consider the following statements: 1. They can be used as carriers of drugs and antigens in the human body. 2. They can be made into artificial blood capillaries for an injured part of human body. 3. They can be used in biochemical sensors. 4. Carbon nanotubes are biodegradable. Which of the statements given above are correct?
